Evolus Inc [EOLS] stock prices are down -2.28% to $13.28 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EOLS shares have gain 4.48% over the last week, with a monthly amount drifted -9.91%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Evolus Inc [NASDAQ: EOLS] stock has seen the most recent analyst activity on January 29, 2024, when Barclays upgraded its rating to a Overweight and also boosted its price target to $16 from $10. Previously, Needham started tracking the stock with Buy rating on June 23, 2022, and set its price target to $18. On May 12, 2022, upgrade upgraded it’s rating to Equal Weight and revised its price target to $10 on the stock. Truist upgraded its rating to a Buy but stick to its price target of $11 on January 20, 2022. Mizuho upgraded its rating to a Buy but $15 remained the price target by the analyst firm on May 06, 2021. H.C. Wainwright reiterated a Buy rating for this stock on April 08, 2021, and upped its price target to $22. In a note dated February 24, 2021, Truist downgraded an Hold rating on this stock but restated the target price of $12.
The stock price of Evolus Inc [EOLS] has been fluctuating between $9.25 and $17.82 over the past year. Currently, Wall Street analysts expect the stock to reach $27 within the next 12 months. Evolus Inc [NASDAQ: EOLS] shares were valued at $13.28 at the most recent close of the market. An investor can expect a potential return of 103.31% based on the average EOLS price forecast.
Analyzing the EOLS fundamentals
The Evolus Inc [NASDAQ:EOLS] reported sales of 266.27M for trailing twelve months, representing a surge of 29.42%. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at -0.12%, Pretax Profit Margin comes in at -0.19%, and Net Profit Margin reading is -0.19%. To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -4.1 and Total Capital is -0.18. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of23.54.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.07 points at the first support level, and at 12.87 for the second support level. However, for the 1st resistance point, the stock is sitting at 13.48, and for the 2nd resistance point, it is at 13.68.
Ratios To Look Out For
It’s worth pointing out that Evolus Inc [NASDAQ:EOLS]’s Current Ratio is 2.40. As well, the Quick Ratio is 2.21, while the Cash Ratio is 1.38. Considering the valuation of this stock, the price to sales ratio is 3.17, the price to book ratio is 152.71.
Transactions by insiders
Recent insider trading involved Parschauer Karah Herdman, Director, that happened on Mar 12 ’25 when 12888.0 shares were sold. Director, Parschauer Karah Herdman completed a deal on Mar 12 ’25 to buy 12888.0 shares. Meanwhile, Avelar Rui sold 2252.0 shares on Dec 23 ’24.
